InGel Therapeutics is a platform technology company developing stem cell therapeutics and biodegradable polymers to enhance and create novel therapies for eye diseases.
InGel was founded in 2021, and is led by a team of committed scientists, engineers, and entrepreneurs.
InGel Therapeutics
Copyright © 2022 InGel Therapeutics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.